Ovarian cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The patient has good compliance and knowingly agreed to participate in the clinical study; (2) Age: 16-80 years old; (3) Stage II-IV ovarian epithelial cancer after standard surgery and chemotherapy; (4)Complete or partial remission is achieved after first-line treatment, and PARPi maintenance therapy is proposed; (5) Blood routine does not exceed I degree of myelmarrow suppression.
Exclusion criteria
Exclusion criteria: (1) Patients with severe primary diseases such as heart, liver and kidney; (2) People with serious mental illness or mental illness; (3) malignant tumors originating in other sites; (4) More than 4 symptom data are missing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse effects of PARPI ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival;Biochemical recurrence;Anxiety assessment;Sleep quality assessment; | — |
Countries
China
Contacts
The Affiliated Hospital of North Sichuan Medical College